SHOOTING FOR THE UNIVERSE By Michael Leviten, Senior Writer CureVac AG is bringing a new modality to the race for a universal flu vaccine...

Biosimilar interchangeability with reference biologics remains a challenge years after product launches, with use depending on physician...

Alnylam’s (NASDAQ:ALNY) trade secrets litigation case against Dicerna (NASDAQ:DRNA) could see the jury influenced by emotive arguments of...

BeiGene’s (NASDAQ:BGNE) BGB-3111 for Waldenström’s macroglobulinemia (WM) will need longer patient follow-up in its Phase I study to...

Corbus Pharmaceuticals’ (NASDAQ:CRBP) Phase II study of anabasum in skin-predominant dermatomyositis could miss its co-primary endpoint...

BY EMILY CUKIER-MEISNER, SENIOR WRITER Dong-A ST Co. Ltd. has spent the last four years building an R&D organization and using its...

Despite an expected increase in the frequency in cybersecurity threats in the near future that will affect networked medical devices,...

• Valuations unreliable given large timeframe to market • Likely EU/US pricing pressures to impact revenue forecasting • Combined...

Western-origin chimeric antigen receptor T-cell (CAR-T) therapies being developed in China face an uncertain regulatory landscape at the...

Proposed legislation across 23 US states to force payers to increase reimbursement of abusedeterrent (AD) opioids will likely face...